Cargando…
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
BACKGROUND: Fungal infections are diagnosed increasingly often in patients affected by hematological diseases and their mortality has remained high. The recent development of new antifungal drugs gives the clinician the possibility to assess the combination of antifungal drugs with in-vitro or in an...
Autores principales: | Cesaro, Simone, Giacchino, Mareva, Locatelli, Franco, Spiller, Monica, Buldini, Barbara, Castellini, Claudia, Caselli, Desireè, Giraldi, Eugenia, Tucci, Fabio, Tridello, Gloria, Rossi, Mario Renato, Castagnola, Elio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871594/ https://www.ncbi.nlm.nih.gov/pubmed/17442100 http://dx.doi.org/10.1186/1471-2334-7-28 |
Ejemplares similares
-
Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting: what is the role for non-pharmacological prophylaxis?
por: Caselli, Désirée, et al.
Publicado: (2011) -
Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis
por: Ullmann, Irina, et al.
Publicado: (2022) -
Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
por: Cesaro, Simone, et al.
Publicado: (2014) -
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011) -
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
por: Viscoli, Claudio, et al.
Publicado: (2014)